BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37310982)

  • 1. Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies.
    Rick AM; Lentscher A; Xu L; Wilkins MS; Nasser A; Tuttle DJ; Megli C; Marques ETA; McElroy AK; Williams JV; Martin JM
    PLoS One; 2023; 18(6):e0287103. PubMed ID: 37310982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in SARS-CoV-2 RBD-Specific IgA and IgG Antibodies in Human Milk From Lactating Women Following the COVID-19 Booster Vaccination.
    Henle AM
    J Hum Lact; 2023 Feb; 39(1):51-58. PubMed ID: 36398916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads.
    Golan Y; Prahl M; Cassidy AG; Gay C; Wu AHB; Jigmeddagva U; Lin CY; Gonzalez VJ; Basilio E; Chidboy MA; Warrier L; Buarpung S; Li L; Murtha AP; Asiodu IV; Ahituv N; Flaherman VJ; Gaw SL
    Front Immunol; 2021; 12():777103. PubMed ID: 34804068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained and Boosted Antibody Responses in Breast Milk After Maternal SARS-CoV-2 Vaccination.
    Ware J; McElhinney K; Latham T; Lane A; Dienger-Stambaugh K; Hildeman D; Spearman P; Ware RE
    Breastfeed Med; 2023 Aug; 18(8):612-620. PubMed ID: 37615566
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-SARS-CoV-2 antibodies in breast milk during lactation after infection or vaccination: A cohort study.
    Olearo F; Radmanesh LS; Felber N; von Possel R; Emmerich P; Pekarek N; Pfefferle S; Nörz D; Hansen G; Diemert A; Aepfelbacher M; Hecher K; Lütgehetmann M; Arck PC; Tallarek AC
    J Reprod Immunol; 2022 Sep; 153():103685. PubMed ID: 36029724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity.
    Conti MG; Terreri S; Terrin G; Natale F; Pietrasanta C; Salvatori G; Brunelli R; Midulla F; Papaevangelou V; Carsetti R; Angelidou A
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S37-S45. PubMed ID: 35535796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination.
    Narayanaswamy V; Pentecost BT; Schoen CN; Alfandari D; Schneider SS; Baker R; Arcaro KF
    Obstet Gynecol; 2022 Feb; 139(2):181-191. PubMed ID: 35104067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Immunization During the Second Trimester with BNT162b2 mRNA Vaccine Induces a Robust IgA Response in Human Milk: A Prospective Cohort Study.
    Kigel A; Vanetik S; Mangel L; Friedman G; Nozik C; Terracina C; Taussig D; Dror Y; Samra H; Mandel D; Lubetzky R; Wine Y
    Am J Clin Nutr; 2023 Sep; 118(3):572-578. PubMed ID: 37479184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Human Milk Antibody Induction, Persistence, and Neutralizing Capacity With SARS-CoV-2 Infection vs mRNA Vaccination.
    Young BE; Seppo AE; Diaz N; Rosen-Carole C; Nowak-Wegrzyn A; Cruz Vasquez JM; Ferri-Huerta R; Nguyen-Contant P; Fitzgerald T; Sangster MY; Topham DJ; Järvinen KM
    JAMA Pediatr; 2022 Feb; 176(2):159-168. PubMed ID: 34757387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth.
    Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Lahav Sher M; Barsha H; Shalabna E; Zolotarevsky A; Lavie O; Kedar R; Riskin-Mashiah S
    Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():148-154. PubMed ID: 35653903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Anti-SARS-CoV-2-Specific Antibody Signatures in Maternal and Infant Blood after COVID-19 Infection versus COVID-19 Vaccination during Pregnancy.
    Sabharwal V; Taglauer E; Demos R; Snyder-Cappione J; Shaik-Dasthagirisaheb YB; Parker-Kelleher S; Hunnewell J; Boateng J; Clarke K; Yuen R; Barnett ED; Wachman EM; Yarrington CD
    Am J Perinatol; 2024 May; 41(S 01):e2970-e2977. PubMed ID: 37774748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Levels After the Pfizer-BioNTech Booster Dose for Coronavirus Disease 2019 (COVID-19) Vaccination During the Second Trimester of Pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Kleifeld S; Cohen N; Sher ML; Zahran H; Barsha H; Assaf W; Shalabna E; Stein N; Lavie O; Kedar R; Riskin-Mashiah S
    Obstet Gynecol; 2022 Aug; 140(2):187-193. PubMed ID: 35852268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels.
    Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S
    Clin Infect Dis; 2022 Aug; 75(1):e603-e610. PubMed ID: 35171998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations.
    Mulleners SJ; Juncker HG; Ruhé EJM; Korosi A; van Goudoever JB; van Gils MJ; van Keulen BJ
    Commun Biol; 2023 Jan; 6(1):100. PubMed ID: 36697496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants.
    Longueira Y; Ojeda DS; Battistelli RBA; Sanchez L; Oviedo Rouco S; Albano D; Guevara E; Valls V; Pando MA; Gamarnik AV
    Front Immunol; 2022; 13():909995. PubMed ID: 36263055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study.
    Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S
    Clin Microbiol Infect; 2022 Mar; 28(3):419-425. PubMed ID: 34740773
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.